title: Antivascular endothelial growth factor-a treatment: new perspectives for high-risk plaque stabilization.
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Toutouzas
authors.forename: John
authors.initials: J
authors.lastname: Karabelas
authors.forename: Sophia
authors.initials: S
authors.lastname: Vaina
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003324:Coronary Artery Disease / Q000188:drug therapy*; D006801:Humans; D042461:Vascular Endothelial Growth Factor A / Q000009:adverse effects / Q000276:immunology*; D042442:Vascular Endothelial Growth Factors / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D000068258:Bevacizumab